| COVID-19 Vaccine |
1 |
1 |
| Immunization |
0 |
0.74 |
| COVID-19 |
0 |
0.66 |
| Vaccines |
0 |
0.62 |
| Rheumatic Disease |
0 |
0.99 |
| Biologic Therapy |
0 |
0.42 |
| Alabama |
0 |
0.17 |
| Arthritis |
0 |
0.17 |
| Myocarditis |
0 |
0.17 |
| Adolescent Medicine |
0 |
0.13 |
| Lupus |
0 |
0.13 |
| Psoriatic Arthritis |
0 |
0.11 |
| Antineoplastic Drug |
0 |
0.09 |
| Glucocorticoid |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.09 |
| Cardiomyopathy |
0 |
0.08 |
| Chest Pain |
0 |
0.08 |
| Vasculitis |
0 |
0.08 |
| Chronic Hepatitis |
0 |
0.06 |
| Connective Tissue Disease |
0 |
0.06 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.5 |
| Systemic Lupus Erythematosus |
0 |
0.45 |
| Acute Respiratory Distress Syndrome |
0 |
0.04 |
| Antigens |
0 |
0.04 |
| Autoimmune Disease |
0 |
0.04 |
| Hepatitis |
0 |
0.04 |
| Hepatitis A |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Immunoglobulin G (IgG) |
0 |
0.04 |
| Immunosuppressive Therapy |
0 |
0.04 |
| Infarction |
0 |
0.04 |
| Kawasaki Disease |
0 |
0.04 |
| Oregon |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Steroids |
0 |
0.04 |
| Thorax |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Tolerance |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Angina Pectoris |
0 |
0.03 |
| Multiple Sclerosis |
0 |
0.02 |
| Myocardial Infarction (MI) |
0 |
0.02 |
| Pain Management |
0 |
0.02 |
| Psoriasis |
0 |
0.02 |